Molecular Target and Action Mechanism of Anti-Cancer Agents
Funding
Conflicts of Interest
References
- National Cancer Institute: Biomarker Testing for Cancer Treatment. Available online: https://www.cancer.gov/about-cancer/treatment/types/biomarker-testing-cancer-treatment (accessed on 14 March 2023).
- Rosen, E.; Drilon, A.; Chakravarty, D. Precision Oncology: 2022 in Review. Cancer Discov. 2022, 12, 2747–2753. [Google Scholar] [CrossRef] [PubMed]
- Wahida, A.; Buschhorn, L.; Frohling, S.; Jost, P.J.; Schneeweiss, A.; Lichter, P.; Kurzrock, R. The coming decade in precision oncology: Six riddles. Nat. Rev. Cancer 2023, 23, 43–54. [Google Scholar] [CrossRef] [PubMed]
- Bower, H.; Bjorkholm, M.; Dickman, P.W.; Hoglund, M.; Lambert, P.C.; Andersson, T.M. Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population. J. Clin. Oncol. 2016, 34, 2851–2857. [Google Scholar] [CrossRef] [PubMed]
- Zarate, A.M.; Espinosa-Bustos, C.; Guerrero, S.; Fierro, A.; Oyarzun-Ampuero, F.; Quest, A.F.G.; Di Marcotullio, L.; Loricchio, E.; Caimano, M.; Calcaterra, A.; et al. A New Smoothened Antagonist Bearing the Purine Scaffold Shows Antitumour Activity In Vitro and In Vivo. Int. J. Mol. Sci. 2021, 22, 8372. [Google Scholar] [CrossRef] [PubMed]
- Schaller, E.; Ma, A.; Gosch, L.C.; Klefenz, A.; Schaller, D.; Goehringer, N.; Kaps, L.; Schuppan, D.; Volkamer, A.; Schobert, R.; et al. New 3-Aryl-2-(2-thienyl)acrylonitriles with High Activity Against Hepatoma Cells. Int. J. Mol. Sci. 2021, 22, 2243. [Google Scholar] [CrossRef] [PubMed]
- Goehringer, N.; Biersack, B.; Peng, Y.; Schobert, R.; Herling, M.; Ma, A.; Nitzsche, B.; Hopfner, M. Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors. Int. J. Mol. Sci. 2021, 22, 8432. [Google Scholar] [CrossRef]
- Roskoski, R., Jr. Targeting BCR-Abl in the treatment of Philadelphia-chromosome positive chronic myelogenous leukemia. Pharmacol. Res. 2022, 178, 106156. [Google Scholar] [CrossRef] [PubMed]
- Huang, W.K.; Shi, H.; Akcakaya, P.; Zeljic, K.; Gangaev, A.; Caramuta, S.; Yeh, C.N.; Branstrom, R.; Larsson, C.; Lui, W.O. Imatinib Regulates miR-483-3p and Mitochondrial Respiratory Complexes in Gastrointestinal Stromal Tumors. Int. J. Mol. Sci. 2021, 22, 600. [Google Scholar] [CrossRef]
- Choi, K.M.; Cho, E.; Bang, G.; Lee, S.J.; Kim, B.; Kim, J.H.; Park, S.G.; Han, E.H.; Chung, Y.H.; Kim, J.Y.; et al. Activity-Based Protein Profiling Reveals Potential Dasatinib Targets in Gastric Cancer. Int. J. Mol. Sci. 2020, 21, 9276. [Google Scholar] [CrossRef]
- Ahmed, M.B.; Ul Islam, S.; Alghamdi, A.A.A.; Kamran, M.; Ahsan, H.; Lee, Y.S. Phytochemicals as Chemo-Preventive Agents and Signaling Molecule Modulators: Current Role in Cancer Therapeutics and Inflammation. Int. J. Mol. Sci. 2022, 23, 5765. [Google Scholar] [CrossRef]
- Guldiken, B.; Ozkan, G.; Catalkaya, G.; Ceylan, F.D.; Ekin Yalcinkaya, I.; Capanoglu, E. Phytochemicals of herbs and spices: Health versus toxicological effects. Food Chem. Toxicol. 2018, 119, 37–49. [Google Scholar] [CrossRef] [PubMed]
- Yang, M.H.; Baek, S.H.; Um, J.Y.; Ahn, K.S. Anti-neoplastic Effect of Ginkgolide C through Modulating c-Met Phosphorylation in Hepatocellular Carcinoma Cells. Int. J. Mol. Sci. 2020, 21, 8303. [Google Scholar] [CrossRef] [PubMed]
- Han, J.M.; Sohng, J.K.; Lee, W.H.; Oh, T.J.; Jung, H.J. Identification of Cyclophilin A as a Potential Anticancer Target of Novel Nargenicin A1 Analog in AGS Gastric Cancer Cells. Int. J. Mol. Sci. 2021, 22, 2473. [Google Scholar] [CrossRef] [PubMed]
- Munkhjargal, A.; Kim, M.J.; Kim, D.Y.; Jeon, Y.J.; Kee, Y.H.; Kim, L.K.; Kim, Y.H. Promyelocytic Leukemia Proteins Regulate Fanconi Anemia Gene Expression. Int. J. Mol. Sci. 2021, 22, 7782. [Google Scholar] [CrossRef] [PubMed]
- Shin, S.B.; Kim, C.H.; Jang, H.R.; Yim, H. Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance. Int. J. Mol. Sci. 2020, 21, 8629. [Google Scholar] [CrossRef] [PubMed]
- Yi, Y.W.; You, K.S.; Park, J.S.; Lee, S.G.; Seong, Y.S. Ribosomal Protein S6: A Potential Therapeutic Target against Cancer? Int. J. Mol. Sci. 2021, 23, 48. [Google Scholar] [CrossRef]
- Barwal, T.S.; Sharma, U.; Bazala, S.; Singh, I.; Jain, M.; Prakash, H.; Shekhar, S.; Sandberg, E.N.; Bishayee, A.; Jain, A. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers. Int. J. Mol. Sci. 2021, 22, 4072. [Google Scholar] [CrossRef]
- Simatou, A.; Sarantis, P.; Koustas, E.; Papavassiliou, A.G.; Karamouzis, M.V. The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL. Int. J. Mol. Sci. 2020, 21, 7570. [Google Scholar] [CrossRef]
- Lee, K.J.; Wright, G.; Bryant, H.; Wiggins, L.A.; Dal Zotto, V.L.; Schuler, M.; Malozzi, C.; Cohen, M.V.; Gassman, N.R. Cytoprotective Effect of Vitamin D on Doxorubicin-Induced Cardiac Toxicity in Triple Negative Breast Cancer. Int. J. Mol. Sci. 2021, 22, 7439. [Google Scholar] [CrossRef]
- Modi, J.; Roy, A.; Pradhan, A.K.; Kumar, A.; Talukdar, S.; Bhoopathi, P.; Maji, S.; Mannangatti, P.; de la Rosa, D.S.; Li, J.; et al. Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein. Int. J. Mol. Sci. 2022, 23, 72. [Google Scholar] [CrossRef]
- Mattei, V.; Santilli, F.; Martellucci, S.; Delle Monache, S.; Fabrizi, J.; Colapietro, A.; Angelucci, A.; Festuccia, C. The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy. Int. J. Mol. Sci. 2021, 22, 3863. [Google Scholar] [CrossRef] [PubMed]
- Czarnomysy, R.; Radomska, D.; Szewczyk, O.K.; Roszczenko, P.; Bielawski, K. Platinum and Palladium Complexes as Promising Sources for Antitumor Treatments. Int. J. Mol. Sci. 2021, 22, 8271. [Google Scholar] [CrossRef] [PubMed]
- Radomska, D.; Czarnomysy, R.; Radomski, D.; Bielawski, K. Selenium Compounds as Novel Potential Anticancer Agents. Int. J. Mol. Sci. 2021, 22, 1009. [Google Scholar] [CrossRef] [PubMed]
- Vallilas, C.; Sarantis, P.; Kyriazoglou, A.; Koustas, E.; Theocharis, S.; Papavassiliou, A.G.; Karamouzis, M.V. Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules. Int. J. Mol. Sci. 2021, 22, 493. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lee, S.-G. Molecular Target and Action Mechanism of Anti-Cancer Agents. Int. J. Mol. Sci. 2023, 24, 8259. https://doi.org/10.3390/ijms24098259
Lee S-G. Molecular Target and Action Mechanism of Anti-Cancer Agents. International Journal of Molecular Sciences. 2023; 24(9):8259. https://doi.org/10.3390/ijms24098259
Chicago/Turabian StyleLee, Seok-Geun. 2023. "Molecular Target and Action Mechanism of Anti-Cancer Agents" International Journal of Molecular Sciences 24, no. 9: 8259. https://doi.org/10.3390/ijms24098259